The Cancer-Protective Potential of Protocatechuic Acid: A Narrative Review

Jorge Cadena-Iñiguez1, Edelmiro Santiago-Osorio2, Nancy Sánchez-Flores2

  • 1Postgraduate College, Campus San Luis Potosí, Salinas de Hidalgo, San Luis Potosí 78622, Mexico.

PubMed

Insights

Protocatechuic acid (PCA), a natural compound found in vegetables, shows significant anticancer potential. Research highlights its diverse biological activities, supporting its use as a promising cancer treatment alternative.

Area of Science:

  • Natural Product Chemistry
  • Oncology
  • Pharmacology

Background:

  • Cancer remains a leading global cause of death, necessitating novel therapeutic strategies.
  • Natural products, particularly phenolic compounds from vegetables, offer promising avenues for cancer control due to their beneficial effects.
  • Protocatechuic acid (PCA) is a phenolic compound with a wide range of documented biological activities.

Purpose of the Study:

  • To review the diverse biological activities of protocatechuic acid (PCA).
  • To focus on the anticancer potential of PCA.
  • To explore PCA's role in modulating molecular pathways crucial for tumor development.

Main Methods:

  • Literature review of existing research on protocatechuic acid.
  • Analysis of studies detailing PCA's biological effects.
  • Examination of research on PCA's impact on cancer-related molecular pathways.

Main Results:

  • Protocatechuic acid (PCA) exhibits numerous beneficial properties, including anti-inflammatory, antioxidant, antimutagenic, and anticancer activities.
  • PCA has demonstrated efficacy in protecting against various health issues, such as metabolic syndrome and organ damage.
  • Evidence suggests PCA influences multiple molecular pathways involved in cancer progression.

Conclusions:

  • Protocatechuic acid (PCA) possesses significant anticancer potential.
  • PCA's multifaceted biological activities make it a promising candidate for cancer therapy.
  • Further research into PCA's mechanisms of action could lead to novel cancer treatment strategies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K